doi: 10.1212/wnl.53.8.1858.
Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease
Affiliations
- PMID: 10563640
- DOI: 10.1212/wnl.53.8.1858
Item in Clipboard
Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease
Neurology.
.
Abstract
We investigated the association of PD with a recently reported I93M mutation of the ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) gene, and with a new and common polymorphic variant S18Y of the same gene. We did not identify the I93M mutation in any of 139 unrelated PD cases or 113 controls. However, S18Y polymorphism carriers had significantly lower risk of PD (odds ratio = 0.53; p = 0.03), and the risk reduction was greater for younger onset cases.
Similar articles
-
The ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism does not confer protection against idiopathic Parkinson's disease.Neurosci Lett. 2000 Oct 27;293(2):127-30. doi: 10.1016/s0304-3940(00)01510-x. Neurosci Lett. 2000. PMID: 11027850
-
Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease.Neuroreport. 1999 Feb 5;10(2):427-9. doi: 10.1097/00001756-199902050-00040. Neuroreport. 1999. PMID: 10203348
-
No genetic association of the ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism with familial Parkinson's disease.J Neural Transm (Vienna). 2001;108(8-9):979-84. doi: 10.1007/s007020170017. J Neural Transm (Vienna). 2001. PMID: 11716150
-
Association between ubiquitin carboxy-terminal hydrolase-L1 S18Y variant and risk of Parkinson's disease: the impact of ethnicity and onset age.Neurol Sci. 2015 Feb;36(2):179-88. doi: 10.1007/s10072-014-1987-y. Epub 2014 Nov 6. Neurol Sci. 2015. PMID: 25370916 Review.
-
Familial Mutations and Post-translational Modifications of UCH-L1 in Parkinson's Disease and Neurodegenerative Disorders.Curr Protein Pept Sci. 2017;18(7):733-745. doi: 10.2174/1389203717666160217143721. Curr Protein Pept Sci. 2017. PMID: 26899237 Review.
Cited by
-
Loss of UCHL1 rescues the defects related to Parkinson's disease by suppressing glycolysis.Sci Adv. 2021 Jul 9;7(28):eabg4574. doi: 10.1126/sciadv.abg4574. Print 2021 Jul. Sci Adv. 2021. PMID: 34244144 Free PMC article.
-
Genetic basis of Parkinson's disease: inheritance, penetrance, and expression.Appl Clin Genet. 2011 Jun 1;4:67-80. doi: 10.2147/TACG.S11639. Print 2011. Appl Clin Genet. 2011. PMID: 23776368 Free PMC article.
-
Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of alpha-synuclein, parkin, and DJ-1 in Caenorhabditis elegans.J Biol Chem. 2005 Dec 30;280(52):42655-42668. doi: 10.1074/jbc.M505910200. Epub 2005 Oct 19. J Biol Chem. 2005. PMID: 16239214 Free PMC article.
-
Lack of evidence for an association between UCHL1 S18Y and Parkinson's disease.Eur J Neurol. 2008 Feb;15(2):134-9. doi: 10.1111/j.1468-1331.2007.02012.x. Epub 2007 Dec 18. Eur J Neurol. 2008. PMID: 18093156 Free PMC article.
-
Ubiquitin Carboxyl-Terminal Hydrolases and Human Malignancies: The Novel Prognostic and Therapeutic Implications for Head and Neck Cancer.Front Oncol. 2021 Jan 29;10:592501. doi: 10.3389/fonc.2020.592501. eCollection 2020. Front Oncol. 2021. PMID: 33585209 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
